AUTHOR=Du Yinke , Qi Zhipeng , Ma Jiangwei , Sun Da , Yao Li , Xu Bin , Liu Wei , Xu Zhaofa , Deng Yu TITLE=Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption JOURNAL=Frontiers in Medicine VOLUME=7 YEAR=2020 URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2020.607849 DOI=10.3389/fmed.2020.607849 ISSN=2296-858X ABSTRACT=

In December 2019, the 2019 novel coronavirus disease (COVID-19), which has been identified to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China and spread across the world. Higher plasma levels of cytokines, including interleukin (IL)-6, IL-2, IL-7, IL-10, and tumor necrosis factor-α, were found in patients with COVID-19, which implies the occurrence of a cytokine storm and its association with disease severity. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. In this study, we report on a patient with COVID-19 who benefited from hemoadsorption.